Johnson & Johnson (BIT:1JNJ)

Italy flag Italy · Delayed Price · Currency is EUR
134.84
+0.04 (0.03%)
Last updated: May 28, 2025
-0.34%
Market Cap 326.55B
Revenue (ttm) 82.47B
Net Income (ttm) 20.13B
Shares Out n/a
EPS (ttm) 8.29
PE Ratio 16.22
Forward PE 14.57
Dividend 4.62 (3.43%)
Ex-Dividend Date Feb 17, 2025
Volume 235
Average Volume 124
Open 135.86
Previous Close 134.80
Day's Range 134.84 - 135.90
52-Week Range 128.30 - 162.26
Beta n/a
RSI 49.39
Earnings Date Jul 16, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange Borsa Italiana
Ticker Symbol 1JNJ
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.